Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

ABBOTT LABORATORIES

ABT · NYSE · CIK 0000001800 · Healthcare · Medical Devices

INSIDER SIGNAL

No active buy signal

3 qualifying P purchase groups
in the current 180-day scoring window

29 Form 4 transaction lines observed in the same window
4 sales · 22 option, withholding, award, gift or other lines

Last qualifying purchase2026-05-07 · Stratton John G · $173.6K

WHY NO ACTIVE SIGNAL?

Purchase activityPresent
Recent buying3 qualifying line group(s)
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Boudreau Philip PEVP AND CFO
○●○
Morrone Louis H.EXECUTIVE VICE PRESIDENT
○▼○
Conroy Kevin TDirector
○○
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLER
○▼
Stratton John GDirector
○●
STARKS DANIEL JDirector
○●
● Purchase▼ Sale○ Other

Showing the six most active owners; 12 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS3
PURCHASE CONCENTRATION71%Largest buyer: STARKS DANIEL J · $926.5K
CLUSTER BUYING · 15D3 insidersPeak activity: 2026-04-23–2026-05-07

Roles in the peak window: Director, EVP AND CFO. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

64.2 / 100

Latest recorded score

→ +0.0 ptsversus the previous recorded snapshot
  1. 64.4
  2. 64.4
  3. 64.3
  4. 64.2
  5. 64.2

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

6Purchases
11Sales
44Other Form 4 lines
47SEC filings · 365 days
BUYING3 qualifying P line(s) · 180 days
SELLING4 sale line(s) · context only
OTHER22 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-10.4%
3M
+11.0%
6M
-1.1%
12M
—

Volatility & liquidity

Volatility
26.9%
Beta
0.59
Avg daily value
USD 986.2M

Valuation

Market cap
USD 175.4B
P/E
32.6×

Fundamentals

Profit margin
14.7%
ROE
12.5%
Industry
Medical Devices

Market data

Price data up to: 2026-09-29 · Price source: OpenBB/yfinance · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · From Yahoo Finance: Market cap, P/E · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
13,634,256
Previous report
19,911,199
Avg daily volume
9,340,141
Days to cover
1.5

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-07Stratton John GPurchase (P)Common shares without par value2,000USD 86.82USD 173,640SEC filing ↗
2026-04-27STARKS DANIEL JPurchase (P)Common shares without par value10,000USD 92.65USD 926,500SEC filing ↗
2026-04-23Boudreau Philip PPurchase (P)Common shares without par value2,200USD 91.50USD 201,300SEC filing ↗
2026-02-04STARKS DANIEL JPurchase (P)Common shares without par value10,000USD 108.73USD 1,087,323SEC filing ↗
2026-01-23Ford Robert BPurchase (P)Common shares without par value18,800USD 107.13USD 2,014,044SEC filing ↗
2021-02-23Kumbier MichellePurchase (P)Common shares without par value2,040USD 122.50USD 249,900SEC filing ↗

Form 4 evidence

61 transaction lines in the latest 365-day window; 711 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-23Conroy Kevin TTax withholding (F)Common shares without par value52,507USD 103.99USD 5,460,203SEC filing ↗
2026-09-02MCCOY JOHN A. JR.Sale (S)Common shares without par value27USD 109.54USD 2,958SEC filing ↗
2026-09-01MCCOY JOHN A. JR.Tax withholding (F)Common shares without par value52USD 110.36USD 5,739SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-23Conroy Kevin TTax withholding (F)Common shares without par value52,507USD 103.99USD 5,460,203SEC filing ↗
2026-09-02MCCOY JOHN A. JR.Sale (S)Common shares without par value27USD 109.54USD 2,958SEC filing ↗
2026-09-01MCCOY JOHN A. JR.Tax withholding (F)Common shares without par value52USD 110.36USD 5,739SEC filing ↗
2026-09-01Boudreau Philip PTax withholding (F)Common shares without par value388USD 110.36USD 42,820SEC filing ↗
2026-08-25Ford Robert BSale (S)Common shares without par value398,832USD 115.85USD 46,204,798SEC filing ↗
2026-08-25Ford Robert BOption exercise / conversion (M)Common shares without par value398,832USD 54.02USD 21,545,946SEC filing ↗
2026-08-12Morrone Louis H.I (I)Common shares without par value12USD 107.99USD 1,296SEC filing ↗
2026-08-11Morrone Louis H.Sale (S)Common shares without par value5,850USD 109.83USD 642,506SEC filing ↗
2026-06-30Morrone Louis H.Tax withholding (F)Common shares without par value269USD 92.71USD 24,939SEC filing ↗
2026-06-27Cushman Elizabeth C.Tax withholding (F)Common shares without par value560USD 94.12USD 52,707SEC filing ↗
2026-05-07Stratton John GPurchase (P)Common shares without par value2,000USD 86.82USD 173,640SEC filing ↗
2026-04-28Moreland Mary KI (I)Common shares without par value5,314USD 94.41USD 501,695SEC filing ↗
2026-04-27STARKS DANIEL JPurchase (P)Common shares without par value10,000USD 92.65USD 926,500SEC filing ↗
2026-04-24Stratton John GAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24STARKS DANIEL JAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24Roman Michael FAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24O'Grady MichaelAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24McKinstry NancyAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24McDew Darren WAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24Kumbier MichelleAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24Gonzalez Patricia PaolaAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24Conroy Kevin TAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24Blount Sally E.Award / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24Babineaux-Fontenot ClaireAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-24Ahuja NitaAward / grant (A)Common shares without par value2,286USD 0.00USD 0SEC filing ↗
2026-04-23Boudreau Philip PPurchase (P)Common shares without par value2,200USD 91.50USD 201,300SEC filing ↗
2026-04-23Boudreau Philip PI (I)Common shares without par value8,909USD 92.04USD 819,984SEC filing ↗
2026-03-23ORVILLE JACOB AAward / grant (A)Common shares without par value13,255USD 0.00USD 0SEC filing ↗
2026-03-02Shroff EricSale (S)Common shares without par value709USD 115.58USD 81,946SEC filing ↗
2026-03-02Salvadori Daniel Gesua SiveSale (S)Common shares without par value885USD 115.58USD 102,288SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerABT
CIK0000001800
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNYSE

Data coverage

Local Form 4 history711 transaction lines from 2020-01-27 to 2026-09-23
7 P purchase lines · 193 S sale lines · 511 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.